SGBI实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (18 Jan 2024 @ 03:24):

Stats
今日成交量	200 000
平均成交量	0.00
市值	314 853
EPS	$-0.000390 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00100 (66.67%)

Insider Trading

Date	Person	Action	Amount	type
2022-06-30	Striepe Thomas	Sell	0	Common Stock
2022-06-30	Schmelz Hubertus	Sell	0	Common Stock
2021-10-13	Schmelz Hubertus	Buy	1 200 000	Common Stock
2021-06-30	Schmelz Hubertus	Sell	0	Common Stock
2021-06-30	Striepe Thomas	Sell	0	Common Stock

INSIDER POWER
0.00
Last 82 transactions
Buy: 3 836 313 \| Sell: 156 955

音量相关性

長: -0.01 (neutral)

短: 0.00 (neutral)

Signal:(41.164) Neutral

Sangui Biotech 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Sangui Biotech 相关性 - 货币/商品

-0.13
( neutral )

-0.16
( neutral )

0.00
( neutral )

0.41
( neutral )

Sangui Biotech 财务报表

Annual	2023
营收:	$93 039.00
毛利润:	$93 039.00 (100.00 %)
EPS:	$-0.000700

FY	2023
营收:	$93 039.00
毛利润:	$93 039.00 (100.00 %)
EPS:	$-0.000700

FY	2022
营收:	$69 190.00
毛利润:	$69 190.00 (100.00 %)
EPS:	$0.000100

FY	2021
营收:	$65 585.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.000974

Financial Reports:

No articles found.

Sangui Biotech

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.